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Abstract
Background: It has been previously shown that combinatorial peptide libraries are a useful tool
to characterize the binding specificity of class I MHC molecules. Compared to other
methodologies, such as pool sequencing or measuring the affinities of individual peptides, utilizing
positional scanning combinatorial libraries provides a baseline characterization of MHC molecular
specificity that is cost effective, quantitative and unbiased.
Results: Here, we present a large-scale application of this technology to 19 different human and
mouse class I alleles. These include very well characterized alleles (e.g. HLA A*0201), alleles with
little previous data available (e.g. HLA A*3201), and alleles with conflicting previous reports on
specificity (e.g. HLA A*3001). For all alleles, the positional scanning combinatorial libraries were
able to elucidate distinct binding patterns defined with a uniform approach, which we make available
here. We introduce a heuristic method to translate this data into classical definitions of main and
secondary anchor positions and their preferred residues. Finally, we validate that these matrices
can be used to identify candidate MHC binding peptides and T cell epitopes in the vaccinia virus
and influenza virus systems, respectively.
Conclusion: These data confirm, on a large scale, including 15 human and 4 mouse class I alleles,
the efficacy of the positional scanning combinatorial library approach for describing MHC class I
binding specificity and identifying high affinity binding peptides. These libraries were shown to be
useful for identifying specific primary and secondary anchor positions, and thereby simpler motifs,
analogous to those described by other approaches. The present study also provides matrices useful
for predicting high affinity binders for several alleles for which detailed quantitative descriptions of
binding specificity were previously unavailable, including A*3001, A*3201, B*0801, B*1501 and
B*1503.
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Background
T cells recognize a complex formed between a major his-
tocompatibility complex (MHC) molecule and an anti-
genic peptide, or epitope. The identification of T cell
epitopes is crucial to facilitate the study of the correlates of
immunity. Different MHC molecules are associated with
different peptide binding specificities, usually referred to
as MHC peptide binding motifs. A large body of literature
relates to the definition of MHC binding motifs for class I
molecules of several different species, including humans,
mice, chimpanzees and macaques (see, e.g., [1], for
review). In general, class I MHC molecules recognize pep-
tides of 9 to 10 residues in length and carrying residues
with similar physiochemical specificity at main anchor
positions. Typically, the main anchors are found in posi-
tion 2 and at the C-terminus of the peptide ligand,
although other anchor arrangements have been described
for several alleles.
A variety of different methods are available to define MHC
peptide binding motifs, each associated with its own
advantages and disadvantages. The most common meth-
ods involve the pool sequencing of naturally presented
MHC ligands or the evaluation of the binding capacity of
individual peptide libraries. The pool sequencing
approach is based on the bulk sequencing of peptides nat-
urally bound to MHC following their elution with acidic
buffers from the MHC peptide binding site. This is a
remarkably simple and effective method, and has been
applied with success in dozens of instances [1]. It imme-
diately and reliably identifies the most dominant binding
requirements of an MHC molecule. An additional unique
advantage of this approach is the fact that it is based on
the characterization of physiologically processed ligands.
Disadvantages associated with this method are that it is
only semi-quantitative, and typically identifies only the
most canonical (stringent) motifs. This can be a drawback
in terms of utilizing this method for epitope predictions,
since it has been shown that many dominant epitopes do
not carry canonical pool sequencing defined motifs. For
example, the prototypical dominant human leukocyte
antigen (HLA) A*0201 restricted influenza matrix 58–66
epitope (sequence GILGFVFTL) [2,3] does not contain the
main anchor pattern associated with the HLA-A*0201
pool sequencing motif, which specifies the presence of L
or M in position 2. Indeed, in a recent study we observed
that 57% (8/14) of the HLA-A*0201 restricted vaccinia-
derived epitopes identified did not conform with the
A*0201 motif derived by pool sequencing analysis [4].
The most common alternative method for defining motifs
is based on establishing quantitative MHC binding assays
in vitro, and then testing series of individual peptides.
These peptides are either single substitution analogs of
high affinity binding epitopes or ligands, or large libraries
of unrelated peptides. This method allows detailed prob-
ing of the relative role and chemical specificity of each
position along the peptide sequence. A concern over this
method when relying solely on single substitution ana-
logs relates to the fact that it might reflect a binding mode
specific to the particular parent peptide utilized as "wild
type", although in practice the specificity patterns identi-
fied by single substitution analysis typically correspond
well with those identified by other methodologies [5-19].
The same binding assay approach can be used to test large
libraries of unrelated peptides (typically 100 or more) of
a given size, and all carrying acceptable main anchor resi-
dues. As each peptide represents a unique sequence, this
approach overcomes the concern associated with the sin-
gle substitution approach that any pattern identified is
dependent on the context of the specific "wild type" lig-
and.
Affinity data from individual peptides can be analyzed
with different computational approaches to derive quan-
titative motifs that elucidate both primary and secondary
influences on binding capacity with great detail (see, e.g.,
[1,9,20-38]). Predictions based on this type of data can
give very accurate quantitative approximations of peptide
binding, and can discriminate between candidate ligands
bearing the same main anchor motifs. The most signifi-
cant drawback of this approach is that it is dependent
upon the availability of panels of several hundreds of
allele specific peptides. As a result, this approach can be
relatively labor intensive and expensive. Also, the selec-
tion of peptide sequences can introduce biases into the
training data, for example by over or under representing
residues at specific sequence positions.
An alternative approach to characterize the binding specif-
icity of MHC molecules is based on the use of positional
scanning combinatorial peptide libraries. Such libraries
consists of combinatorial mixtures of large numbers of
different peptides all sharing a single residue at a certain
position. Measuring the affinity of such a library effec-
tively evaluates the average influence of the shared residue
on binding in a diverse set of surrounding sequences.
Thus, an estimate of the binding contribution of all 20 res-
idues in a 9-mer peptide can be derived by measuring the
affinity of a set of 180 mixtures. This approach has been
utilized successfully to determine specificity for several
different applications, including analyses of the specifici-
ties associated with T cell receptor (TCR) recognition [39],
proteosomal cleavage [40], and transporter associated
with antigen processing (TAP) transport [41], as well as
the identification of T cell epitopes [42,43]. Their efficacy
in characterizing MHC binding specificity was first
explored in several studies starting over a decade ago
[32,44-46]. Matrices derived from analysis of combinato-
rial libraries have been found to perform well in the pre-Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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diction of peptides with high MHC binding affinity
[32,47,48]. Buus, in his visionary review of MHC studies,
proposed the systematic use of combinatorial libraries a
"Human MHC Project", directed at a complete mapping
of human immune reactivities [49,50].
Like the single substitution or peptide library approaches,
data generated from positional scanning combinatorial
library studies provide quantitative motifs. The unique
advantage of using positional scanning combinatorial
libraries is that they can be re-used for every allele, repre-
senting potentially very significant cost savings. Retesting
the same probes for each allele also removes the risk of
introducing bias into the set of tested ligands. These
advantages have led us to systematically apply the use of
combinatorial libraries to a set of 19 class I MHC alleles.
In this large scale evaluation, we test if this approach
works uniformly across different alleles. We compare its
prediction performance to that of bioinformatics machine
learning algorithms. We also developed a heuristic
approach to convert the combinatorial library affinity
data into a classical representation of primary and second-
ary anchor positions, which makes them directly compa-
rable to those obtained in pool sequencing. Finally, we
test the ability of these matrices in practical applications
to identify MHC binding peptides and T cell epitopes.
Methods
Positional scanning combinatorial libraries and peptide 
synthesis
The combinatorial library was synthesized as previously
described [51]. Each pool in the library contains 9-mer
peptides with one fixed residue at a single position. With
each of the 20 naturally occurring residues represented at
each position along the 9-mer backbone, the entire library
consisted of 180 peptide mixtures.
Peptides utilized in screening studies were synthesized as
described elsewhere [16], or purchased as crude material
from Mimotopes (Minneapolis, MN/Clayton, Victoria,
Australia), Pepscan Systems B.V. (Lelystad, Netherland) or
A and A Labs (San Diego, CA). Peptides synthesized for
use as radiolabeled ligands were synthesized by A and A
Labs and purified to >95% homogeneity by reverse phase
HPLC. Purity of these peptides was determined using ana-
lytical reverse-phase HPLC and amino acid analysis,
sequencing, and/or mass spectrometry. Peptides were
radiolabeled with the chloramine T method [52]. Lyophi-
lized peptides were re-suspended at 4–20 mg/ml in 100%
DMSO, then diluted to required concentrations in PBS
+0.05% (v/v) nonidet P40 (Fluka Biochemika, Buchs,
Switzerland).
MHC purification and peptide binding assays
MHC purification and quantitative binding assays based
on the inhibition of binding of a high affinity radiola-
beled ligand were performed essentially as described else-
where [18,52]. HLA A*0201, A*6802, B*0702, B*0801,
B*2705, B*3501, B*5101, B*5301, and B*5401 mole-
cules were purified from EBV transformed homozygous B
cell lines, as previously described [15,16,18,52-55]. For
A*3201, B*1501, B*5801 and B*5802, the WT47,
SPACH, AP and 35841 cell lines were utilized, respec-
tively. A*3001 molecules were obtained from the RSH cell
line, or kindly provided by Dr. Soren Buus. B*1503 mol-
ecules were purchased from Pure Protein L.L.D. (Okla-
homa City, OK), or kindly provided by Dr. Soren Buus. All
HLA cell lines are from the IHWG cell bank (Fred Hutch-
inson Cancer Research Center). Mouse class I molecules
were purified from P815 (H-2 Dd and Kd), CH27 (H-2 Kk),
or EL-4 (H-2 Db) lines, as previously described [10,52].
For the B*1501, B*1503, A*3201 and A*3001 assays, the
artificial sequences AQIDNYNKF (peptide 3128.0001),
YQAVVPLVY (peptide 3054.0065), RILHNFAYSL (pep-
tide 1454.42) and KTKDYVNGL (peptide 1428.02) were
utilized as the radiolabeled probes, respectively. Radiola-
beled ligands for all other assays were as previously
described [15,16,18,52-55]. In competition assays, each
mixture or individual peptide was tested in 3 or more
independent experiments for its capacity to inhibit the
binding of the radiolabeled peptide. The concentration of
peptide yielding 50% inhibition of the binding of the
radiolabeled peptide was calculated. Under the condi-
tions utilized, where [label] < [MHC] and IC50 ≥ [MHC],
the measured IC50 values are reasonable approximations
of KD.
Bioinformatic analysis
IC50 nM values for each mixture were standardized as a
ratio to the geometric mean IC50 nM value of the entire
set of 180 mixtures, and then normalized at each position
as previously described [17,18] so that the value associ-
ated with the optimal value at each position corresponds
to 1. For each position, an average (geometric) relative
binding affinity (ARB) was calculated, and then the ratio
of the ARB for the entire library to the ARB for each posi-
tion was derived. We have denominated this ratio, which
describes the factor by which the normalized geometric
average binding affinity associated with all 20 residues at
a specified position differs from that of the average affinity
of the entire library, as the specificity factor (SF). As calcu-
lated, positions with the highest specificity will have the
highest SF value. Primary anchor positions were then
defined as those associated with an SF > 2.4. This criterion
identifies positions where the majority of residues are
associated with significant decreases in binding capacity.Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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Secondary anchors were identified based on the standard
deviation of residue specific values at each position.
To identify predicted binders, all possible 9-mer peptides
in vaccinia WR sequences were scored using the matrix
values, where the final score for each peptide represents
the product of the matrix value for the corresponding res-
idue at each position. Algorithms derived by combining
positional scanning combinatorial library and individual
peptide data sets were generated using the stabilized
matrix method (SMM) approach, as previously described
[56].
Characteristics of the Study Population
Healthy males and females between 25 and 49 years of
age were used in this study. Exclusion criteria were body
weight of <45.4 kg and/or established pregnancy. Institu-
tional Review Board approval and appropriate consent
were obtained.
Peripheral Blood Mononuclear Cell (PBMC) Isolation and 
HLA Typing
PBMCs were isolated from heparinized blood by gradient
centrifugation with a Histopaque-1077 (catalogue no.
H8889, Sigma) [57], and the cells were cryopreserved in
liquid nitrogen in 10% DMSO/FBS. Each donor's PBMCs
were typed for HLA-A and -B by high-resolution PCR
(Atria Genetics, San Francisco, CA).
Ex Vivo Primary ELISPOT Assay
Peptides were synthesized, and divided into groups
according to their predicted HLA-A and HLA-B-restriction.
PBMCs from individuals with the corresponding haplo-
type were incubated at 2 × 105 per well in the presence of
individual peptides at 10 μg/ml, or a control pool with 24
peptides derived from commonly encountered pathogens
(EBV, CMV, and influenza A virus) [58,59]. The ELISPOT
assays were performed as described previously [60].
Responses against DMSO alone were subtracted from the
experimental values. To assess statistical significance, a
one-tailed Student t test was performed in which the trip-
licate values of each condition were compared with those
of the negative controls. The criteria for positivity in a sin-
gle experiment was set to ≥ 20 net spot-forming cells
(SFCs)/106, a stimulation index (SI) ≥ 2.0, and p ≤ 0.05.
Each experiment was performed twice. Epitopes were
defined as peptides giving a positive response in 2/2
experiments using PBMC from a single donor.
Results
Evaluation of the positional scanning combinatorial library 
approach for predicting HLA A*0201 binding peptides
Previous studies in other laboratories have demonstrated
that the combinatorial approach performs well in predict-
ing binders to several murine MHC class I molecules
[32,46,47]. To verify that the same holds for human MHC
molecules, we initially used the positional scanning com-
binatorial library with the best characterized human allele
HLA A*0201, for which detailed primary and secondary
anchor motifs have been described (see, e.g.,
[3,9,16,34,61,62]). Also, several different predictive
methods for this allele are widely available, and have been
rigorously tested and compared (see, e.g., [36,47]).
Previously, we compared the efficacy of several prediction
approaches for A*0201 [47]. In that analysis, 3 algorithms
hosted by the Immune Epitope Database (IEDB) [63-65]
were evaluated in cross-validation, and 16 other publicly
available algorithms were evaluated directly by scoring a
library of over 3000 peptides whose capacity to bind
A*0201 was known. The performance of each method
was then evaluated using receiver operator curves (ROC),
and calculating the area under the curve (AUC). The per-
formance of the 16 directly evaluated algorithms, meas-
ured by AUC, ranged from a best of 0.935 to 0.788 (see
[47] and Table 1). Overall, the average performance was
0.864, with a median score of 0.871.
To gauge the relative performance of the combinatorial
approach, each of the 9-mer mixtures was tested for its
capacity to inhibit the binding of a high affinity radiola-
beled ligand to purified A*0201 molecules. The measured
IC50 nM values for each mixture are shown in Additional
Table 1: Performance of several methods for predicting A*0201 
binders.
Method AUC Rank
arbmatrixa 0.935 1
netmhcanna 0.934 2
hla_a2_smm 0.922 3
bimas 0.920 4
mapppB 0.920 4
mhcpathwaya 0.915 6
multipredann 0.883 7
mapppS 0.871 8
syfpeithi 0.871 8
rankpep 0.836 10
hlaligand 0.816 11
mhcpred 0.814 12
svmhc 0.814 12
multipredhmm 0.796 14
pepdist 0.789 15
predep 0.788 16
Average 0.864
Median 0.871
Combinatorial library 0.909
1. With the exception of the positional scanning combinatorial library, 
these data have been previously reported [47], and are shown here 
for reference purposes.Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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file 1 [see Additional file 1]. IC50 nM values were then
normalized as described in the Materials and Methods.
The resulting A*0201 matrix (Table 2) was used to score
the same 3089 9-mer peptides used above. Good agree-
ment between predicted IC50 and measured IC50 was
noted (r2 = 0.53), and an AUC of 0.909 was measured
(Table 1 and Figure 1). This performance is above both
the average and median found for 10 of the 16 other algo-
rithms available on the Internet. This performance is nota-
ble in that the combinatorial library utilizes only 180 data
points as the training set. By contrast, the top performing
ARB, ANN and SMM-based algorithms were developed
using a training set with over 10-fold more data points.
While information of training set size is unavailable for
the remaining algorithms, given the general availability of
A*0201 binding data, it is reasonable to assume that these
algorithms have utilized training sets of similar size. Fur-
thermore, the training set for the combinatorial approach
does not overlap with the test set, and is thus completely
unbiased, unlike the case for most of the tools utilized in
the comparison [47]. Taken together, the data presented
in this section have provided further demonstration of the
efficacy of using a positional scanning combinatorial
library for identification of MHC class I binding peptides.
Table 2: Positional scanning combinatorial library derived matrix describing 9-mer binding to HLA A*0201.
Position
R e s i d u e 123456789
A 0.114 0.002 0.431 0.895 0.377 0.715 0.334 0.259 0.105
C 0.032 0.002 0.222 0.201 0.758 0.435 0.260 0.178 0.005
D 0.008 0.002 0.465 0.915 0.114 0.211 0.149 0.161 0.003
E 0.015 0.030 0.037 0.647 0.193 0.838 0.536 0.492 0.038
F 1.000 0.004 0.630 0.359 0.322 0.364 0.696 0.784 0.084
G 0.089 0.009 0.098 0.537 0.270 0.152 0.194 0.358 0.008
H 0.005 0.002 0.270 0.168 0.184 0.207 0.345 0.164 0.002
I 0.121 0.057 0.537 0.321 0.300 0.843 1.000 0.082 0.327
K 0.114 0.012 0.016 0.372 0.182 0.088 0.041 0.199 0.002
L 0.054 1.000 0.568 0.661 0.263 0.555 0.346 0.357 0.181
M 0.251 0.186 1.000 0.291 1.000 0.363 0.353 0.264 0.075
N 0.067 0.006 0.159 0.823 0.329 0.725 0.385 0.177 0.003
P 0.003 0.003 0.056 0.792 0.109 0.328 0.957 1.000 0.003
Q 0.019 0.140 0.200 0.582 0.104 0.566 0.703 0.190 0.002
R 0.084 0.002 0.019 0.233 0.220 0.128 0.072 0.306 0.002
S 0.103 0.009 0.167 1.000 0.179 0.190 0.533 0.377 0.008
T 0.094 0.038 0.145 0.189 0.199 1.000 0.236 0.267 0.015
V 0.062 0.098 0.246 0.282 0.263 0.734 0.284 0.243 1.000
W 0.057 0.002 0.584 0.637 0.331 0.197 0.628 0.352 0.005
Y 0.107 0.008 0.875 0.303 0.235 0.150 0.946 0.609 0.002
Average 0.054 0.012 0.203 0.440 0.249 0.348 0.347 0.287 0.013
SD 3.9 6.6 3.3 1.8 1.8 2.1 2.3 1.8 7.4
SF 2.28 10.36 0.61 0.28 0.49 0.35 0.35 0.43 9.42
Library average: 0.123
Positional scanning combinatorial library based predictions  for HLA A*0201 Figure 1
Positional scanning combinatorial library based pre-
dictions for HLA A*0201. Scatter plot depicting the rela-
tionship between the predicted score generated from the 
A*0201 matrix and measured IC50 nM values for 3089 9-mer 
peptides. Binding assays were performed as described in the 
materials and methods for peptides previously [47] utilized 
to compare various publicly available prediction tools. Pep-
tides were scored using the matrix as described in the text.
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Generation and validation of positional scanning 
combinatorial library matrices for additional human and 
murine class I alleles
Encouraged by the results obtained in the context of
A*0201, we derived, and make herein available to the sci-
entific community, combinatorial library matrices for an
additional 14 HLA (A*3001, A*3201, A*6802, B*0702,
B*0801, B*1501, B*1503, B*2705, B*3501, B*5101,
B*5301, B*5401, B*5801 and B*5802) and 4 mouse (H-
2 Dd, Kd, Db and Kk) class I molecules. The measured IC50
values are provided in Additional file 1 [see Additional file
1], and will also be submitted to the Immune Epitope
Database (IEDB) for hosting at the IEDB Analysis resource
[66]. The IC50 values for each mixture were normalized as
described above. The resulting matrix values are tabulated
in Additional file 2 [see Additional file 2]. For each allele,
the matrices identified a reproducible, characteristic,
binding pattern.
Identification of primary and secondary anchor positions 
by the positional scanning combinatorial library approach
To compare the results of combinatorial matrices with
those from pool sequencing and single residue substitu-
tions, and in order to meaningfully summarize the rather
large amount of data in each scoring matrix, it is desirable
to describe MHC binding in terms of simple motifs. The
first step in defining such a motif is identifying the peptide
positions that have the strongest influence on binding.
As before, A*0201 was first utilized as a model system.
A*0201 binds peptides utilizing the peptide residues in
position 2 and at the C-terminus as main anchors. At both
main anchor positions hydrophobic or aliphatic residues
are preferred or tolerated. Additional influences on bind-
ing capacity are contributed by residues at secondary posi-
tions, most prominently positions 1, 3, and 7, where both
positive and deleterious influences can be noted [9].
To derive an objective criteria useful for identifying pri-
mary anchor positions, we reasoned that positions associ-
ated with the highest specificity would be associated with
the lowest average affinity, as the majority of residues
would not be tolerated. Accordingly, we first calculated
the average relative binding affinity (ARB) for each posi-
tion, representing the geometric mean of the values at
each position (see Table 2), normalized to the average for
the entire library. We have denominated this ratio as the
specificity factor (SF). Analysis of the A*0201 data
revealed that a SF value of ≥ 2.4 could demarcate only
position 2 and the C-terminus as the main anchor posi-
tions (Table 3). To test the general applicability of the SF
method for identifying primary anchors, we generated SF
values for each of the 18 other alleles for which we have
derived combinatorial matrices (Table 3). For 13 of the 18
additional alleles examined (72%), a SF > 2.4 identified
all main anchor positions identified by pool sequencing
or other motif analyses. Overall, 33/38 (87%) anchor
positions identified previously were identified using this
criteria. Notable exceptions were A*3001 and B*0801.
Table 3: Specificity factors derived from positional scanning combinatorial library matrices identify primary anchor positions.
SF1
System Allele P1 P2 P3 P4 P5 P6 P7 P8 P9
HLA A*0201 2.28 10.36 0.61 0.28 0.49 0.35 0.35 0.43 9.42
A*3001 1.41 0.72 7.54 0.27 0.52 0.65 0.96 0.45 3.31
A*3201 0.89 2.85 0.57 0.64 0.81 0.44 1.06 0.50 5.69
A*6802 1.32 4.59 1.13 0.62 0.48 0.38 0.41 0.84 3.75
B*0702 0.59 13.70 1.43 0.48 0.42 0.40 0.30 1.16 3.06
B*0801 0.85 1.05 1.10 0.31 2.53 2.78 0.35 0.54 2.44
B*1501 0.70 2.11 0.72 0.53 0.37 0.71 0.49 1.07 12.95
B*1503 0.73 3.22 0.92 0.34 0.48 0.43 1.08 0.74 8.17
B*2705 0.77 36.73 0.77 0.50 0.85 0.79 0.41 0.39 0.83
B*3501 0.94 3.55 0.75 0.86 0.41 0.61 0.54 0.71 4.79
B*5101 1.34 2.57 0.59 0.29 0.46 0.59 0.37 0.44 39.03
B*5301 2.07 3.68 1.29 0.41 0.59 0.36 0.57 0.36 5.80
B*5401 1.02 9.12 2.21 0.28 0.32 0.32 0.31 0.67 8.30
B*5801 0.81 4.49 0.71 0.43 0.68 0.45 1.02 0.64 4.54
B*5802 1.47 1.79 0.74 0.37 0.57 0.57 2.08 0.50 4.10
H-2 Db 1.18 1.07 1.39 0.35 3.61 0.28 0.42 0.79 4.93
Dd 0.37 3.24 17.14 0.21 0.59 0.22 2.29 0.20 3.89
Kd 0.31 52.55 0.61 0.51 0.73 0.38 0.75 0.23 4.14
Kk 0.36 8.69 0.56 0.35 1.06 0.32 1.20 0.49 8.13
1. SF > 2.4, identifying primary anchor positions, are highlighted by bold font.Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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Using a higher or lower threshold resulted in lower corre-
spondence with previously described motifs.
To define secondary anchor positions a different approach
was utilized. We reasoned that positions associated with
the highest standard deviation (SD) between residues
would correspond to those most affected positively or
negatively by secondary binding effects. Again analyzing
the A*0201 data, it was found that a SD > 3 could success-
fully identify positions previously described as secondary
anchors (Figure 2). Using a higher or lower threshold
resulted in lower correspondence with previously
described motifs. Applying this criterion to the other alle-
les, one or more dominant secondary anchor positions
could be identified for most alleles (Figure 2). In the
majority of these cases, the dominant secondary anchors
were found to be in positions 1, 3 and 7. This pattern of
secondary interactions is largely in agreement with a pre-
vious analysis [67].
Validation of the positional scanning combinatorial library 
approach: identifying primary anchor preferences
We next examined how well the preference patterns at the
identified main anchor position agreed with those identi-
fied by pool sequencing or peptide library methods. Again
starting with the well characterized A*0201 allele, we
found that residues with relative affinities within about
10-fold of the optimal residue correspond to those previ-
ously described as preferred at the position 2 and C-termi-
nal main anchors (Tables 2 and 4). More specifically, at
position 2, using a 10-fold threshold identified L, M and
Q as the most preferred residues. By contrast, the pool
sequencing approach identified L and M. Similarly, at the
C-terminus, V, I, L and A were identified as the preferred
residues by the combinatorial libraries, compared to V
and L from pool sequencing. In this respect, the prefer-
ences identified by the 10-fold criteria for combinatorial
libraries are about mid-way between the more stringent
motif defined by pool sequencing analyses, and the
extended motif identified by peptide screening
approaches [16].
The same criteria were then applied to the set of 18 addi-
tional alleles. Again, the patterns identified by the combi-
natorial libraries largely followed those previously
described (Table 4). As was the case with A*0201, the 10-
fold criteria applied to the combinatorial library data
tended to identify a broader motif than identified by pool
sequencing. However, when a more stringent threshold
(e.g., 5-fold) is utilized, a narrower motif very similar to
that described by pool sequencing is identified.
This analysis revealed several unexpected designations.
The identification of position 3 as a main anchor for
A*3001 binding, instead of position 2, is in disagreement
with the published literature, but was not entirely unex-
pected based on analyses using single amino acid substi-
tution peptides (Sidney and Sette, unpublished
observations). The preference in position 2, identified as
a dominant secondary anchor here, appears to be more
towards small residues (V, T, and A) rather than aromat-
ics, as indicated by pool sequencing, although these latter
residues are still well tolerated. The preference at position
3 was found to be for basic residues. Pool sequencing had
suggested a preference for hydrophobic residues at the C-
terminus. While the combinatorial library generated
motif is not in disagreement with this general specificity,
the identification of an A3-supertype like preference for K
was unexpected. However, subsequent MHC peptide
binding studies by others (Harndahl and Buus et al, IEDB
submission 1000945, [63]) and us (Sidney and Sette,
unpublished observations) have confirmed this prefer-
ence. Positions 1 and 2 were found to be dominant sec-
ondary anchors. This observation, in consideration with
the discrepancy identified between the pool sequencing
and positional scanning combinatorial libraries, suggests
that A*3001 may be able to bind peptides using multiple
different anchor arrangements.
In other cases, specifically B*1501, B*5802 and B*2705,
no clear anchors were defined at either the N- or C-termi-
nal end, where a more diffuse chemical specificity is
apparent. A similar failure to identify dominant signals at
more than one anchor residue has also been noted for sev-
eral alleles when using pool sequencing methods (see e.g.,
[68]).
Primary and secondary anchor positions for 19 HLA and H-2  class I alleles defined using positional scanning combinatorial  peptide library matrices Figure 2
Primary and secondary anchor positions for 19 HLA 
and H-2 class I alleles defined using positional scan-
ning combinatorial peptide library matrices. Maps of 
primary and secondary anchor positions as defined using the 
combinatorial library data. Primary anchors (blue shading) 
were identified using specificity factors (SF), as secondary 
anchor positions (green shading) were determined on the 
basis of standard deviation (SD), as described in the text.
Anchor score
System Allele P1 P2 P3 P4 P5 P6 P7 P8 P9
HLA A*0201
A*3001
A*3201
A*6802
B*0702
B*0801
B*1501
B*1503
B*2705
B*3501
B*5101
B*5301
B*5401
B*5801
B*5802
H-2 Db
Dd
Kd
KkImmunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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A detailed motif for A*3201 has not, to our knowledge,
been previously made available. It has been suggested that
this allele would be a member of the A1-supertype, and
the motif identified herein is congruent with that associa-
tion. However, peptide binding studies have not yet been
able to confirm that this allele shares significant repertoire
overlap with other alleles of this supertype.
Application of positional scanning combinatorial libraries: 
Predicting MHC binding peptides
The performance of combinatorial library matrices was
further evaluated with 5 selected alleles (A*3001,
A*3201, B*0801, B*1501 and B*1503). Each of these
alleles is relatively common in the human population,
but large sets of high affinity binding peptides are not, to
our knowledge, currently available. Using these matrices,
all 9-mer sequences from vaccinia Western Reserve (WR)
strain were scored utilizing the product of the matrix value
for the corresponding residue at each position. For each
allele, the top 300 scoring 9-mers peptides, corresponding
to approximately the top 0.5%, were synthesized and
tested for binding. The binding data are summarized in
Additional file 3 [see Additional file 3]. It was found that
on average 68% of the peptides selected bound their cor-
responding allele with an affinity of 100 nM or better,
with a minimum of 58% in the case of B*1501, and a
maximum of 78% in the case of A*3001. By comparison,
in the cases of A*3001, B*0801 and B*1501, where bind-
ing data was available for sets of peptides with poorer
scores, it was found that peptides with scores equivalent
to those in the lower 50% range were only rarely binders,
with rates of binding in the 1 to 5% range (Figure 3).
Taken together, these data further validate the use of com-
binatorial libraries as a basis for predictive algorithms.
Also, the present analysis has provided sets of high affinity
binders derived from vaccinia WR for 5 relatively com-
mon HLA class I alleles.
Application of positional scanning combinatorial libraries: 
Predicting T cell epitope candidates
We initially wanted to test the sets of high affinity peptides
identified from vaccinia virus in DryVax immunized
donors, similar to a previous investigation with donors
carrying HLA alleles from common supertypes [69]. How-
ever, at the time of this study, we were unable to enroll a
large enough number of newly vaccinated donors with the
desired matching HLA alleles. We instead decided to vali-
date the ability of combinatorial libraries to aid in the
identification of T cell epitopes from influenza recognized
in human donors for which we could enroll multiple
Table 4: Comparison of main anchor motifs identified using positional scanning combinatorial libraries with those using other 
approaches.
Published motif Combinatorial library motif
System Allele P2 P3 P5 P6 P9 P2 P3 P5 P6 P9
HLA A*0201 LM [IVATQ] VL [MIAT] L [MQ] VI [LA]
A*3001 YF L RK KA [LVIY]
A*3201 [MLITVQS] [WIFYHT] TMIQLVS [A] FIYLW
A*6802 [LMIVATQS] [LMIVAT] VTS [IALMP] VALI
B*0702 P L [FWYIVMA] P [VA] LFAVI [M]
B*0801 RK RK LIVM RHKF F [RH] LFMVIA [E]
B*1501 QL FY FY [M]
B*1503 QK FY QMK [LHASE] F [MY]
B*2705 R KRLYANFMIH R
B*3501 P YFMLI [WVA] PA FYM [A]
B*5101 APG VI [FWYLMA] PA [GQVS] I [V]
B*5301 P WFL [YIVMA] PA [IV] FC [IW]
B*5401 P [FWYLIVMA] A [P] AV
B*5801 AST FW STA [VG] WFIY [MC]
B*5802 ST R F IFL [MW]
H-2 Db N LIVM N [L] IML [VF]
Dd G P RK LFI G P FLI [C]
Kd YF LIVM Y ILV [M]
Kk E LIVM E [D] IV [FL]
1. Indicates residues preferred in the indicated anchor positions, as reported in the published literature. Motifs are as identified by pool sequencing 
motifs. Residues in brackets are additional residues identified on the basis of peptide binding studies.
2. Indicates residues preferred in the indicated anchor positions, as identified by the combinatorial library approach. Motifs are as identified using an 
ARB > 0.2 threshold. Residues in brackets are additional residues identified when the threshold is lowered to 0.1.Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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donors with the HLA alleles A*3001, A*3201, and
B*1501.
To make optimal use of both the combinatorial library
data and the individual peptide binding data for these
alleles, we utilized the SMM (stabilized matrix method)
approach [56], which can combine these data to compute
second generation matrices. These second generation
matrices have been found to perform better than predic-
tions based on either approach alone. All 9-mer peptides
present in a representative set of Influenza A H1N1 and
H3N2 strains were scored using the second generation
matrices for A*3001, A*3201, and B*1501 as shown in
Additional file 4 [see Additional file 4], and for each allele
the top 100 scoring peptides were synthesized.
The predicted high-affinity-binding peptides were tested
for their ability to elicit T cell responses from human
donors with matching HLA. PBMCs from donors were iso-
lated from leukopherisis or general blood donation vol-
unteers, and HLA-typed by high-resolution PCR. In total,
13 healthy donors of 25–49 years of age were included in
the study, including 3 donors for A*3001 and A*3201,
and 8 for B*1501. Cryopreserved PBMCs were assayed
with individual peptides from the set(s) corresponding to
the donor's haplotype, and the reactivity was determined
using IFNγ ELISPOT assays. Positive epitopes were
defined as described in the Methods.
From these experiments, epitopes were successfully iden-
tified for each allele (Table 5). Specifically, 2, 1, and 13
epitopes were identified in patients typed as A*3001,
A*3201 and B*1501, respectively. However, no peptide
was recognized in more than one donor. To the best of our
knowledge, each of these represent novel epitopes, and
together are the first set of influenza virus derived epitopes
based on predictions for A*3001, A*3201 and B*1501.
Discussion
Because peptide binding to MHC is a requirement to elicit
a T cell response, algorithm-based approaches predicting
peptide binding are often utilized as a first screen to iden-
tify epitopes derived from large pathogens. In the present
study, we have utilized 9-mer positional scanning combi-
natorial libraries to characterize the peptide binding spe-
cificities of several mouse and human class I alleles. When
the corresponding positional scanning combinatorial
library data were utilized to generate matrices for the pre-
diction of binders derived from vaccinia, it was found that
in all cases examined between 58 and 78% of the top
0.5% scoring peptides were high affinity binders, depend-
ing on the specific allele considered. The biological rele-
vance of quantitative motifs derived from combinatorial
library analyses were validated by identifying several
epitopes derived from influenza A virus that were recog-
nized by PBMCs from human donors. This study therefore
provides a set of 19 uniformly generated matrices that can
be directly applied to predict MHC peptide binding and T
cell epitope candidates.
An implicit feature of the approach is that it provides a
detailed quantitative motif for each MHC specificity
examined. However, it is often useful to summarize MHC
binding specificity in the more simple terms of primary
Table 5: Influenza epitopes.
Putative 
restriction
Peptide Sequence Average 
SFC/10^6
A*3001 NP.358 GTKVIPRGK 32
A*3001 PB2.219 KTRFLPVAG 45
A*3201 NA.369 KLRSGYETF 57
B*1501 HA.91 LLPARSWSY 67
B*1501 HA.113 RSKAFSNCY 25
B*1501 HA.219 YVSVVSSHY 83
B*1501 HA.361 GMIDGWYGF 104
B*1501 M1.164 QMVTTTNPL 73
B*1501 NA.32 LVTTVTLHF 59
B*1501 NA.363 KSNSSRRGF 110
B*1501 NA.371 KSRSGYETF 137
B*1501 NP.404 GQISVQPTF 59
B*1501 NP.404 GQISTQPTF 42
B*1501 NS1.134 MLKANFSVI 108
B*1501 PB1.623 RLCNPLNPF 91
B*1501 PB2.198 LQNCKISPL 59
Efficacy of positional scanning combinatorial library based  predictions for 3 HLA class I alleles Figure 3
Efficacy of positional scanning combinatorial library 
based predictions for 3 HLA class I alleles. The percent 
of peptides scoring within a specified percentile range that 
bind A*3001, A*3201 or B*1501. Peptides were scored using 
the corresponding combinatorial library matrix. Peptides 
were then assigned a percentile score indexed to the percen-
tile associated with 9-mer peptides derived from vaccinia 
with the same matrix score. About 60,000 9-mers derived 
from the vaccinia WR sequence were scored to develop the 
indices.
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anchor motifs. This "minimalist" approach dates back to
the earliest studies of MHC binding, where specificities
were defined using pool sequencing or single amino acid
substitution analyses. These methods were very good at
characterizing the most prominent features of allele spe-
cific motifs, and the resulting motifs have generally
formed the syntax with which MHC binding is described.
To extend the utility of the combinatorial approach, we
have developed a heuristic approach to translate the
matrix data generated by the combinatorial libraries into
the more simple motifs that are the idiom of MHC stud-
ies. In the majority of cases, generalizable parameters
could be defined that allowed the identification of main
and secondary anchor positions congruent with those
defined by other approaches.
The majority of HLA class I molecules whose binding spe-
cificity have been described by crystal structure, pool
sequencing or peptide binding studies, the main anchor
interactions of the peptide almost invariably involve the
residues at position 2 and the C-terminus of the peptide.
This pattern also appears to be true for most macaque and
chimpanzee class I alleles studied to date. As evidenced by
the cases of A*3001 and B*0801, the combinatorial
library analysis suggests that the paradigm of position 2/
C-terminus anchor spacing for MHC peptide binding is
not always true. This has been reported previously in the
case of B*0801 [70], where positions 3 and 5, in addition
to the C-terminus, have been identified as primary
anchors. Although this exact pattern was not duplicated
by the combinatorial analysis, the present data do con-
firm the importance of positively charged residues in the
middle of the peptide for conferring high affinity binding
capacity. The ability to pick up unexpected binding pat-
terns of MHC alleles is one of the key advantages of the
combinatorial libraries, which have no prior expectations
on which positions are likely to be important for
MHC:peptide interactions.
In our previous HLA supertype classification study [71],
B*0801 was considered an outlier on the basis of it's
somewhat unique, for HLA, use of positions 3 and 5 as
main anchor positions. This designation was also made
by Lund [72] and Hertz [73]. Others [74,75] have classi-
fied it with alleles we [71] and others [72,73] have
assigned as members of the B7-supertype. In the present
study, the combinatorial library analysis suggested that
positions 5 and 6 are important (in addition to the C-ter-
minus) for peptide binding. As such, the present analysis
does not provide sufficient evidence to suggest that
B*0801 should be assigned to a specific supertype, which
are largely defined by position 2 (and C-terminus) specif-
icity. We can note that proline, the B7-supertype associ-
ated position 2 specificity, does appear to be well
tolerated in position 2 by B*0801. Also, our own unpub-
lished binding data suggests that there may be some cross-
reactivity between B*0702 and B*0801. However, this
potential cross-reactivity has not been examined in
enough detail at this point to draw any conclusions.
Previously, B*3501, B*5101, B*5301, and B*5401 were
assigned to the B7-supertype [71-73], which describes a
set of HLA alleles sharing a preference for proline as the
position 2 main anchor. In the present study, the combi-
natorial library analysis confirmed this preference, but,
surprisingly, also indicated that alanine was well tolerated
by these alleles in position 2. This would suggest that
overlap may exist in the repertoires of at least some B7-
supertype alleles with alleles outside the B7-supertype,
and in particular those associated with the B58- and or
B62-supertypes. While the binding data we have to date
suggest that the majority of instances of repertoire overlap
for B7-supertype alleles will fall within the B7-supertype,
and that proline is the most dominant preference in posi-
tion 2, evidence for some cross-reactivity is also quite
apparent. Indeed, a recent study [76] has found a high
degree of cross-recognition of epitopes between alleles
associated with different supertypes. Future studies will
hopefully shed additional light on this issue.
In utilizing combinatorial libraries to characterize MHC
specificity and identify binders, the approach we have
implemented is computationally simple. We have largely
utilized relative binding values for each residue/position
coordinate. To predict binders, we have assumed the inde-
pendent binding of peptide side chains, and represented
the predicted binding propensity as a product of each
coordinate. There are other ways to process the raw data
for the purpose of generating prediction matrices, or to
define anchor positions. To facilitate further investigation
of prediction approaches by the bioinformatic commu-
nity, we have here provided both the raw and processed
data for over a dozen different HLA, and 4 H-2, class I alle-
les. We believe that this data will be of value to the com-
munity for the prediction of binders and epitopes, at least
for several alleles not previously characterized in detail.
We compared the prediction performance of the combi-
natorial library with a set of 16 bioinformatic approaches
for the best characterized human MHC allele, HLA
A*0201. While several algorithms outperformed the com-
binatorial library, this has to be taken into perspective, as
these algorithms are based on up to ten times more train-
ing data. Even more surprising, the combinatorial library
nevertheless proved highly competitive, with a better pre-
diction quality than 10 out of 16 algorithms. Taken
together, the combinatorial libraries minimally provide a
very solid baseline characterization of MHC binding spe-
cificity, which can be generated both quickly and with cost
effectiveness.Immunome Research 2008, 4:2 http://www.immunome-research.com/content/4/1/2
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Using combinatorial library based matrices to identify sets
of candidate peptides, epitopes were successfully identi-
fied in patients typed as A*3001, A*3201 and B*1501.
Notably, however, no peptide was recognized in more
than one donor. This diversity of responses is similar to
what was noted previously for mapping T cell responses to
vaccinia-derived peptides in human donors. Because of
the small number of A*3001 and A*3201 donors tested,
it is possible we have under estimated the number of pos-
itive responses. Other factors may also be responsible for
the lower response rates observed. The donor pool uti-
lized represents an outbred population, and almost all of
the donors were heterozygous at both the A and B loci.
Thus, the diverse donor responses may reflect the different
influences of other MHC alleles in shaping the overall T
cell repertoire. Similarly, that dominant epitopes recog-
nized in multiple donors were not identified may be due
to the fact that the set of donors is representative of diverse
histories of exposure to different viral strains.
The epitope identification aspect of the study was not pur-
sued to the level and detail of our previous studies (e.g.,
[69]). Several factors are responsible for this, including
the fact that while the alleles studied are not rare, neither
are they prevalent, making it resource intensive to identify
a sufficient number of additional donors. As a result, the
identified peptides represent potential leads of a prelimi-
nary nature. At the same time, the data does help demon-
strate that the matrices derived in the study are useful for
epitope identification, even if the epitope identification
study was not ideal. Furthermore, to the best of our
knowledge, each of the epitopes identified in the present
study represent novel epitopes, and together are the first
set of influenza virus derived epitopes based on predic-
tions for A*3001, A*3201 and B*1501.
Conclusion
The present study has extended observations from previ-
ous studies [32,44,46,48,49] showing the usefulness of
positional scanning combinatorial libraries for identify-
ing MHC class I binding peptides. Herein we have made
available combinatorial library based matrices for 19 class
I alleles of human and mouse origin, including several
that have not previously been characterized in detail.
These libraries have also been shown to be useful for iden-
tifying specific primary and secondary anchor positions,
and thereby simpler motifs, analogous to those described
by other approaches. For A*3001, A*3201, B*0801,
B*1501 and B*1503, sets of vaccinia WR derived peptides
that bind with high affinity have been identified. These
peptides represent candidates for future studies towards
the identification of epitopes derived from vaccinia, a
virus of high interest for the development of viral vector
based vaccines, in addition to its well-known use as a vac-
cine against smallpox. Finally, we have also identified sev-
eral epitopes derived from influenza that are recognized
in HLA A*3001, A*3201 and B*1501 donors.
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